8-K: Quantum X Labs Inc. Completes Acquisition of Quantum Israel

Quantum X Labs Inc. (formerly Viewbix Inc.) has filed a Form 8-K detailing the completion of its acquisition of Quantum X Labs Ltd., including pro forma financial information.

Summary

• Quantum X Labs Inc. (formerly Viewbix Inc.) has filed a Form 8-K to report on the completion of its acquisition of Quantum X Labs Ltd. (Quantum Israel).
• The filing includes audited financial statements for Quantum Israel as of December 31, 2025, and unaudited pro forma combined financial information reflecting the acquisition.
• The acquisition was previously announced on March 4, 2026, and Quantum Israel is now a wholly-owned subsidiary.
• The pro forma financial information is presented to show the combined entity as if the acquisition had occurred earlier, but it does not necessarily reflect future results.
• The filing also includes consents from Kesselman & Kesselman, the independent auditor for Quantum Israel.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on a completed acquisition and providing historical and pro forma financial data. While the acquisition itself is a strategic positive, the disclosed going concern issues for the acquired entity temper the overall sentiment.

Positives

• Completion of the acquisition of Quantum X Labs Ltd., integrating its quantum technology and intellectual property into Quantum X Labs Inc.
• The pro forma financial information provides a view of the combined entity's potential financial position and results of operations.
• The company has secured audited financial statements for the acquired entity, Quantum Israel, as of December 31, 2025.

Negatives

• Quantum X Labs Ltd. (the acquired entity) has incurred losses since inception and negative cash flows from operating activities, raising substantial doubt about its ability to continue as a going concern.
• The pro forma financial information is not necessarily indicative of future results and does not reflect potential synergies or integration costs.
• The acquired entity's financial statements indicate a material uncertainty related to its ability to continue as a going concern, dependent on securing additional financing.

Risks

• The acquired entity, Quantum X Labs Ltd., faces substantial doubt regarding its ability to continue as a going concern due to incurred losses and negative operating cash flows.
• The continuation of Quantum X Labs Ltd.'s operations is dependent on securing additional financing.
• The pro forma financial information is based on preliminary estimates and assumptions that could change, potentially leading to material differences in actual results.
• The ongoing conflict in Israel may affect the company's operations and financial condition, although no material adverse impact was reported for 2025.

Future Outlook

The unaudited pro forma combined financial information does not necessarily reflect what the combined company's results of operations, balance sheets, or cash flows would have been had the acquisition been completed in prior periods, nor does it necessarily indicate future results. The company has not provided specific forward-looking guidance in this filing.

Management Comments

• The unaudited pro forma combined financial information included in this report does not necessarily reflect what the Company's results of operations, balance sheets or cash flows would have been during the periods presented had the Acquisition been completed in prior periods and does not necessarily indicate what the Company's results of operations, balance sheets, cash flows or costs and expenses will be in the future.
• In the opinion of management, all adjustments necessary to present fairly the unaudited pro forma condensed combined financial information have been made.

Industry Context

StockSavvy.ai notes that this filing signifies a consolidation within the quantum technology sector, with Quantum X Labs Inc. integrating the capabilities of Quantum X Labs Ltd. This move aligns with broader industry trends of companies seeking to bolster their quantum computing and AI-driven solutions through strategic acquisitions.

Legal Proceedings

• The Company believes that any legal matters it may be subject to in the ordinary course of business are neither probable to result in a liability nor can result in a material adverse effect on its business, financial condition, results of operations or cash flows.

Related Party Transactions

• As of December 31, 2025, related parties receivable balance of $112 thousand consisted of expenses paid by the Company on behalf of its unconsolidated entities.
• During the year ended December 31, 2025, $78 thousand was provided by a related party to fund the activities of Quantum X Labs Ltd.

Stakeholder Impact

• Shareholders: The acquisition integrates Quantum Israel's quantum technology, potentially enhancing the combined entity's future value. However, the going concern issues of Quantum Israel may introduce uncertainty.
• Creditors: The financial health of the acquired entity, Quantum Israel, which faces going concern issues, could be a concern.
• Employees: Integration of teams and operations may lead to changes for employees of both Quantum X Labs Inc. and Quantum Israel.

Next Steps

• The company is providing disclosures related to the acquisition of Quantum X Labs Ltd. as required.
• Audited financial statements of Quantum Israel and unaudited pro forma combined financial information are being filed.

Key Dates

Keywords

Quantum X Labs Inc., Quantum Israel, Acquisition, Form 8-K, Financial Statements, Pro Forma, Quantum Technology, Going Concern